Results 21 to 30 of about 3,266,701 (358)
Hematology Reports, 2019 A unique case of primary refractory FLT3-itd mutated acute myeloid leukemia in an elderly patient, who achieved completed morphological remission, and FLT3-itd negativity, following 9 cycles of azacitadine in combination with escalating doses of donor ...
Claire Horgan +5 more
doaj +1 more source
Indian Heart Journal, 2020 Objective: End stage heart failure is a lethal disease with a dismal 5 year survival. Heart transplantation has proven to be a highly effective modality of treatment in appropriately selected group of such patients.
K.R. Balakrishnan +9 more
doaj +1 more source
Circulation, 2019 Sensitization, defined as the presence of circulating antibodies, presents challenges for heart transplant recipients and physicians. When present, sensitization can limit a transplantation candidate's access to organs, prolong wait time, and, in some ...
Monica M Colvin +11 more
semanticscholar +1 more source
Primary graft dysfunction after heart transplantation: a thorn amongst the roses
Heart Failure Reviews, 2019 Primary graft dysfunction (PGD) remains the leading cause of early mortality post-heart transplantation. Despite improvements in mechanical circulatory support and critical care measures, the rate of PGD remains significant.
S. Singh +3 more
semanticscholar +1 more source
Journal of Cardiothoracic Surgery, 2019 Background The donor’s mode of brain death (BD), being associated with impairment of myocardial function and hemodynamic performance, impacts the prognosis of the heart transplantation (HTx) recipient.
Eilon Ram +7 more
doaj +1 more source
Diagnostics, 2020 Background. We sought to evaluate the long-term effects of angiotensin receptor blocker–neprilysin inhibitor (ARNI) therapy on reverse remodeling of the failing myocardium in HFrEF patients. Methods. We performed a prospective non-randomized longitudinal
Gregor Poglajen +7 more
doaj +1 more source
Nihon Naika Gakkai Zasshi, 1998 While nearly 4,000 patients undergo heart transplantation (HTx) every year in the world, only 27 HTx were performed since February, 1999, because of very strict Organ Transplantation Law in Japan. All were treated with triple immunosuppressive regimen.
Norihide, Fukushima, Hikaru, Matsuda
openaire +6 more sources
Journal of Clinical MedicineHeart transplantation (HTx) remains the last therapeutic resort for patients with advanced heart failure. The present work is a clinically focused review discussing current issues in heart transplantation. Several factors have been associated with the outcome of HTx, such as ABO and HLA compatibility, graft size, ischemic time, age, infections, and the
Nikolaos Chrysakis +7 more
openaire +3 more sources
Panoramic on Epigenetics in Coronary Artery Disease and the Approach of Personalized Medicine
Biomedicines, 2023 Epigenetic modifications play a fundamental role in the progression of coronary artery disease (CAD). This panoramic review aims to provide an overview of the current understanding of the epigenetic mechanisms involved in CAD pathogenesis and highlights ...
Marcello Bergonzini +13 more
doaj +1 more source
Pediatric Blood &Cancer, EarlyView.ABSTRACT Purpose Metabolic syndrome (MetS) is a common complication in survivors of childhood acute lymphoblastic and myeloid leukemia (AL), and a major risk factor for premature cardiovascular disease, type‐2‐diabetes, and metabolic dysfunction‐associated steatotic liver disease (MASLD).
Visentin Sandrine +10 more
wiley +1 more source